SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Coeptis Therapeutics COEP
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
Stock Market Manager Weekly Update: November 12th, 2024
Black Swan Connection Newsletter Signup Breaking News Veterans Day Before you do anything else, take a moment to remember all those that made the ultimate sacrifice to ensure every day …
Stock Market Manager Weekly Update: August 12th, 2024
Black Swan Connection Newsletter Signup Breaking News As everyone is painfully aware markets are all over the place. With a war looming in the middle east and a tight election …
Stock Market Manager Weekly Update: May 24th, 2024
Black Swan Connection Newsletter Signup Breaking News Memorial Day Before you do anything else, take a moment to remember all those that made the ultimate sacrifice to ensure every day …
Description
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017 and is headquartered in Wexford, PA.
Contact Information
105 Bradford Rd
Suite 420
Wexford, PA 15090
Financial Reporting/Disclosure
Reporting Status : U.S. Reporting: SEC Reporting
Latest Report : 12/31/22 10-Q
CIK : 0001759186
Fiscal Year End : 12/31
NASDAQ : COEP
Profile Data
SIC – Industry Classification : Not Available
Incorporated In : NV, USA
Year of Inc. : Not Available
Employees : Not Available
Company Officers/Contacts
Dave Mehalick ┃ Chairman, President and Chief Exec. Officer
Christine Sheehy ┃ CFO
Dan Yerace┃ Director and VP of Operations
Dr. Everin Alici Ph.D., MD ┃ Head of Gene Cell Therapy Group
Dr. Hans-Gustaf Ljunggren Ph.D., MD ┃